Cambridge Heart files $20 million shelf

By Laura Lutz

Des Moines, July 21 - Cambridge Heart, Inc. filed a $20 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The filing includes common stock, preferred stock, debt securities and warrants. The securities may be structured as convertibles.

The company will use the proceeds for general corporate purposes.

Bedford Mass.-based Cambridge Heart develops products for the non-invasive diagnosis of cardiac disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.